Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hospira, inc. - oxaliplatin (unii: 04zr38536j) (oxaliplatin - unii:04zr38536j) - oxaliplatin 5 mg in 1 ml - oxaliplatin, in combination with infusional fluorouracil and leucovorin, is indicated for: oxaliplatin is contraindicated in patients with a history of a hypersensitivity reaction to oxaliplatin or other platinum-based drugs. reactions have included anaphylaxis [see warnings and precautions (5.1)] . risk summary based on its direct interaction with dna, oxaliplatin can cause fetal harm when administered to a pregnant woman. the available human data do not establish the presence or absence of major birth defects or miscarriage related to the use of oxaliplatin. reproductive toxicity studies demonstrated adverse effects on embryo-fetal development in rats at maternal doses that were below the recommended human dose based on body surface area (see data) . advise a pregnant woman of the potential risk to a fetus. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data animal data pregna

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - oxaliplatin - solution for infusion - 5mg/1ml

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - oxaliplatin 50mg;   - powder for infusion - 50 mg - active: oxaliplatin 50mg   excipient: lactose monohydrate

Jordaania - inglise - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - oxaliplatin 50 mg/10ml - 50 mg/10ml

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

sandoz inc. - oxaliplatin (unii: 04zr38536j) (oxaliplatin - unii:04zr38536j) - oxaliplatin injection, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: - adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumor. - treatment of advanced colorectal cancer. oxaliplatin injection should not be administered to patients with a history of known allergy to oxaliplatin injection or other platinum compounds [see warnings and precautions (5.1)] . pregnancy category d based on direct interaction with dna, oxaliplatin injection may cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies of oxaliplatin injection in pregnant women. reproductive toxicity studies in rats demonstrated adverse effects on fertility and embryo-fetal development at maternal doses that were below the recommended human dose based on body surface area. if this drug is used during prenancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potent

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

actavis pharma, inc. - oxaliplatin (unii: 04zr38536j) (oxaliplatin - unii:04zr38536j) - oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: - adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumor. - treatment of advanced colorectal cancer. oxaliplatin should not be administered to patients with a history of known allergy to oxaliplatin or other platinum compounds [see warnings and precautions (5.1)] .  pregnancy category d based on direct interaction with dna, oxaliplatin may cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies of oxaliplatin in pregnant women. reproductive toxicity studies in rats demonstrated adverse effects on fertility and embryo-fetal development at maternal doses that were below the recommended human dose based on body surface area. if this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. women of childbearing p

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - oxaliplatin -

Kanada - inglise - Health Canada

hospira healthcare ulc - oxaliplatin - powder for solution - 50mg - oxaliplatin 50mg - antineoplastic agents

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - oxaliplatin -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - oxaliplatin -